ClinicalTrials.govpublic full text
Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients
metastatic breast cancer, advanced breast cancer, quality of life, toxicity, older patients, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 805323
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.